Changeflow GovPing European Union

Recent changes

Favicon for changeflow.com

EPO Patent Bulletin: Improved Bakery Composition

The European Patent Office published patent EP3481205C0 concerning an improved bakery composition on March 18, 2026. This patent relates to specific IPC classifications including A21D and C12N, and is designated for several European states.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Publication: Polynucleotide Influenza Vaccine

The European Patent Office has published a patent application (EP2026030759A1) for a polynucleotide influenza vaccine encoding hemagglutinin and neuraminidase. The publication date is March 18, 2026, and it includes IPC classifications related to vaccines and molecular biology.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Application: Methods for Selectively Targeting Neuronal Pathways

The European Patent Office has published patent application EP2026030664A1 concerning methods for selectively targeting neuronal pathways. The publication date is March 18, 2026. The designation of the inventor has not yet been filed.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent EP3134509B1: Modulating Fat Storage via Gut Bacteria

The European Patent Office has granted patent EP3134509B1, titled 'Modulating Fat Storage via Gut Bacteria'. This patent relates to methods for altering population levels of Christensenellaceae in the gut to modulate fat storage, potentially impacting the development of treatments for metabolic disorders.

Routine Rule Pharmaceuticals
Favicon for changeflow.com

EPO Patent Granted: Nerve Tissue Production Method EP3211072B1

The European Patent Office has granted patent EP3211072B1 for a method of producing nerve tissue. The patent, listing multiple inventors, is effective March 18, 2026, and applies to designated states within the European Union.

Routine Rule Pharmaceuticals
Favicon for changeflow.com

EPO Patent Grant: Cellular Component Preservation EP3422848B1

The European Patent Office has granted patent EP3422848B1 for a method of preserving cellular components from cells using a preservative. This patent is effective March 18, 2026, and covers inventors Mark Connelly, Chandra Galla Rao, and Denis Smirnov.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Application: Protein Design Systems and Methods

The European Patent Office has published patent application EP2026030717A1 concerning protein design systems and methods. The application was published on March 18, 2026, and includes classifications related to biotechnology and artificial intelligence. The inventors have not yet been designated.

Routine Notice Intellectual Property
Favicon for changeflow.com

EPO Patent Application: Enforced Mitophagy System

The European Patent Office has published patent application EP2026030758A2 concerning an enforced mitophagy system designed to reduce mitochondrial abundance in cells and organisms. The application details a method for controlling mitochondrial levels, potentially impacting biotechnology and medical research fields.

Routine Notice Healthcare
Favicon for changeflow.com

EPO Patent EP3134509C0: Modulation of Fat Storage

The European Patent Office (EPO) has published patent EP3134509C0 concerning the modulation of fat storage by altering gut bacteria populations. This patent, related to biotechnology and pharmaceuticals, was published on March 18, 2026.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent: Synthesis of 1-Butanol from Carbon Dioxide by Engineered Bacteria

The European Patent Office has published a patent application (EP2026030726A1) detailing the synthesis of 1-butanol from carbon dioxide using engineered bacteria. The patent application was published on March 18, 2026, and lists designated states across Europe.

Routine Notice Pharmaceuticals

Showing 301–310 of 1,115 changes

1 29 30 31 32 33 112

Get European Union alerts

Daily digest of regulatory changes. AI-summarized, no noise.

Free. Unsubscribe anytime.